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BDNF Val66Met Polymorphism on Functional MRI
During n-Back Working Memory Tasks
Chih-Chung Chen, MD, Chi-Jen Chen, MD, Dean Wu, MD, Nai-Fang Chi, MD, Po-Chih Chen, MD,
Yen-Peng Liao, Hung-Wen Chiu, and Chaur-Jong Hu, MD
Abstract: Val66Met polymorphism on the brain-derived neurotrophic
factor (BDNF) gene is associated with hippocampal pathology and
impaired episodic memory. However, the influence of this polymorph-
ism on working memory (WM) performance and patterns of brain
activation is controversial. This study investigated the effects of BDNF
Val66Met polymorphism on functional magnetic resonance imaging
(fMRI) during n-back WM tasks in healthy middle-aged adults.
A total of 110 participants without subjective or objective cognitive
impairment underwent BDNF genotyping. Eleven Met allele carriers
and 9 noncarriers underwent fMRI during WM tasks.
The WM performance was similar between the 2 groups. Increased
brain activation in response to increases inWMloadswas observed in both
groups. The Met allele carrier group showed consistently lower brain
activation in the right superior frontal gyrus (SFG) and themiddle occipital
gyrus than that of the noncarrier group (P< 0.001). No brain region
showed increased activation during WM tasks in the Met allele group.
BDNF Val66Met polymorphism may affect the WM network. Met
allele carriers have lower brain activation in the right SFG and middle
occipital gyrus than do noncarriers during WM tasks. Defective devel-
opment of the WM network during brain maturation or differentiation is a
possible mechanism. Additional studies with a larger sample and longer
follow-up period are warranted.
(Medicine 94(42):e1586)
Abbreviations: AD8 = eight-item informant interview to differentiate
aging and dementia, BDNF = brain-derived neurotrophic factor,
BOLD = blood oxygenation level dependent, fMRI = functional
magnetic resonance image, MMSE = mini-mental status examination,
SFG = superior frontal gyrus, WM = working memory.
INTRODUCTION
B rain-derived neurotrophic factor (BDNF) is widely distrib-uted in the central nervous system. BDNF and its receptor
tropomyosin receptor kinase B are highly expressed in the
hippocampus, hypothalamus, and cortex.1 BDNF participates
in activity-dependent plasticity processes, such as long-term
potentiation, learning, and memory.2 Reduction in hippo-
campal BDNF expression has been associated with normal
aging and age-related memory decline.3 A common single-
nucleotide polymorphism on theBDNF gene, rs6265, results in
an amino acid change from valine to methionine at codon
66 (Val66Met) in the prodomain of BDNF. This polymorphism
influences intracellular BDNF trafficking and secretory
regulation.
BDNF Val66Met polymorphism also affects memory
function and motor learning and has been linked to several
neuropsychiatric disorders.4,5 Several studies have demon-
strated an association between BDNF Val66Met and
impaired cognitive function in the memory and nonmemory
domains.6–11 The polymorphism is also closely related to
hippocampal pathology. Egan et al demonstrated that hippo-
campal N-acetyl aspartate levels in Met allele carriers
decreased in a genetic and dose-dependent manner by using
magnetic resonance spectroscopic imaging.6 Bueller et al
showed that the Met allele was associated with an 11%
reduction in the volume of hippocampal formation.12 In
addition, a meta-analysis in 2012 showed lower total hippo-
campal volumes in Met allele carriers.13 Although most
studies on BDNF Val66Met polymorphism demonstrated that
Met allele carriers have a higher cognitive deficit risk, studies
have also documented greater cognitive impairment in Met
allele noncarriers.14,15
Working memory (WM) capacity can be measured using
an n-back task in functional magnetic resonance imaging
(fMRI). The participant monitors a series of stimuli and
responds when a stimulus presented is same as that presented
n trials previously. Val66Met polymorphism psychometrically
and physiologically affects the hippocampus-dependent episo-
dic memory.6,16–18 However, studies on the Met allele and WM
performance in healthy participants have yielded contradictory
results. Two studies have revealed poor WM performance in
Met allele carriers.9–11 However, several studies have revealed
no considerable difference between carriers and noncar-
riers.6,10,19,20 In addition, a previous fMRI study demonstrated
disrupted hippocampal deactivation in Met allele carriers per-
forming n-back WM tasks.6 A recent study showed significant
overactivation of the right dorsolateral prefrontal cortex and the
superior parietal lobule in healthy Met allele carriers under a
high (2-back> 0-back) WM load, even though their WM
performance was noninferior.20 The authors proposed that
Met allele carriers have a compensatory mechanism for main-
taining normal task performance; however, these results have
not been reproduced in other experiments. In the present study,
we compared changes of brain activation under low and high
WM loads between healthy middle-aged Met allele carriers
and noncarriers.
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MATERIALS AND METHODS
Participants
A total of 110 people who underwent physical examination
at Taipei Medical University-Shuang Ho Hospital participated
in this study. All participants provided written informed con-
sent, and the study was approved by the Taipei Medical
University Joint Institutional Review Board. The participants
completed the eight-item informant interview to differentiate
aging and dementia (AD8) questionnaire21 and were assessed
using the mini-mental status examination22 (MMSE) for sub-
jective and objective cognitive impairment. People with a
history of psychiatric disorders and an AD8 score> 2 or MMSE
score< 26 were excluded. Therefore, people without cognitive
impairment were selected for further genetic analysis, and 85
Met allele carriers and 25 noncarriers were identified. Eleven
participants among the Met allele carriers (9 heterozygotes
and 2 homozygotes) underwent fMRI analysis. Nine age-
and sex-matched participants were recruited from the sample
of noncarriers.
Genotyping
Genomic DNA was extracted using the Blood Genomic
DNA Extraction Midiprep System. DNA was amplified using
PCR in a thermal cycler with a BDNF forward primer, 50-
GCTGACACTTTCGAACAT-30, and reverse primer, 50-
ACCCTCATGGACAAGTTT-30. The PCR mixture contained
1mg of DNA, 100 ng of primers, 50mM each dNTP, 1 PCR
buffer, and 2.5 units of Taq polymerase. The reactions were
carried out through 35 cycles of denaturation for 1.5 minutes at
94 8C, annealing for 1.5 minutes, and extension for 2.5 minutes
at 72 8C. After PCR amplification, 5 units of restriction enzyme,
NIaII, were added to each reaction mixture and incubated
overnight at 37 8C in a water bath to differentiate Val66Met
polymorphism.23 Electrophoresis of the digested products was
conducted on a 4% agarose gel stained with ethidium bromide.
Gel images were collected using an image system, and the
digestion fragment size was evaluated through comparison with
size marker.
Working Memory Task
The n-back WM protocol applied in our previous study.24
Before the fMRI scan, we explained the procedure of the task to
all participants. In order to reduce anxiety, each of them was
supervised to practice the task before entering the scanner room.
We designed 3 conditions in the n-back tasks – 0-, 1-, and 2-
back. In 0-back condition, the participants decided whether the
number shown currently matched the predetermined number
assigned by the examiner. This condition used a minimal WM
load and the functional image presented as a baseline contrast in
our study. In 1-back condition, the participants decided whether
the number shown currently matched the previous number. This
condition used more WM load than in 0-back condition. In 2-
back condition, the participants decided whether the number
shown currently matched the number 2-back in the sequence.
This condition used more WM load than in 1-back condition.
During WM tasks in the scanner, participants could see the
stimuli on an overhead screen and respond by pressing a
response pad. We applied block design for the functional
imaging study. Each condition is comprised of a single run.
Each run contained 3 epochs. Each epoch contained consequent
12 numbers presentation in a 30-second period, followed by
fixation on a crosshair in another 30-second period. Participants
used a pad near right hand to respond. If the current presented
number was the target, they used right index finger to press the
pad, if not, used right middle finger. The numbers of correct and
incorrect responses were recorded. The task performance was
only valid when accuracy rate of 0- and 1-back conditions
reached 85% or above.
Imaging Methods
The 3.0T MR system (Discovery MR750, GE Healthcare)
with 8-channel head coilwas used to receive brain imaging signals.
We applied an established protocol to obtain the functional ima-
ging.25 Standard echo-planar imaging method with the protocol of
TR¼ 3000ms, TE¼ 35ms, FA¼ 908, FOV¼ 230mm2,
matrix¼ 64 64, 40 slices, slice thickness¼ 3mm, and interslice
gap¼ 1mm, was used for rapid image data acquisition. T1-
weighted data were obtained by the protocol of TR¼ 8.2ms,
TE¼ 3.2ms, TI¼ 450ms, FA¼ 128, FOV¼ 24Omm2,
matrix¼ 256 256, 160 slices, and voxel size¼ 0.9375
 0.9375 1mm3. T2-weighted data were obtained by the
protocol of TR¼ 5700ms, TE¼ 100ms, FOV¼ 230mm2,
matrix¼ 416 416, 20 slices, slice thickness¼ 5mm, interslice
gap¼ 2mm, and number of excitations¼ 1.
Data Preprocessing
We followed the protocol in another fMRI study by our
group.25 In brief, the functional imaging data were preprocessed
using Statistical Parametric Mapping 5 (Wellcome Department,
University College London, UK) implemented in MATLAB
Version 7.9 (MathWorks, Sherborn, MA). The functional
images were realigned with the first volume of the series by
the method of rigid-body transformation procedure and resli-
cing to reduce motion artifacts during task performance. After
the head motion effect was removed, the volumes were spatially
normalized to the Montreal Neurological Institute EPI template.
In order to increase the signal-to-noise radio and decreased
anatomical variation among participants, 3D Gaussian filter
with a full width at half maximum of 6 6 6mm3 was used to
spatially smooth the normalized EPI images.
Statistical Analysis
Data of the 2 groups, including demographic information,
neuropsychological test (MMSE and AD8), and accuracy rate of
n-back WM tasks, were compared using 2-tailed t-tests or Chi-
square tests. For functional dataset analysis, general linear
model of hemodynamic response analysis implemented in
Statistical Parametric Mapping 5 was employed. To obtain
the brain activation patterns for each group, preprocessed scans
for all participants were input into the general linear model. Two
sets of contrast images were created in each group, including
comparison between 0- and 1-back (1> 0) and 1- and 2-back
(2> 1) conditions. The probability threshold value was set at
0.001 uncorrected with a minimum cluster extent of 3 contig-
uous voxels. Activation difference maps for 1> 0-back and
2> 1-back conditions between Met allele carriers and noncar-
riers were generated by second-level multiparticipant or
between-group random effect analyses. The 1-sample t-test
was applied for within-group analyses. The 2-sample t-test
was applied for between-group analyses.
RESULTS
Demographic information, neuropsychologic test results,
and accuracy rate of WM tasks are shown in Table 1. The 2
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study groups did not differ significantly regarding sex, age,
MMSE score, AD8 score, and group accuracy rate of WM tasks
(P> 0.05). However, we observed that the accuracy rate of WM
tasks tended to decline whenWM load increased in both groups.
Activation maps of the Met allele carriers and noncarriers
during the n-back task are shown in Figure 1. The maps were
generated on a standard brain atlas with the probability
threshold value set at 0.001 with a minimum cluster extent
of 3 voxels. Both groups showed activation in the bilateral
frontal and parietal regions, in association with increased WM
load, which was consistent with the activation of the WM
circuitry. In both groups, activation in the left frontal region
was more prominent than that in the right frontal region,
possibly representing right index or middle finger movement
during task responses. Contrast images comparing between 0-
and 1-back (1> 0) and 1- and 2-back (2> 1) in each group are
shown in Figure 2. Both groups exhibited increased brain
activation in response to increase in the WM load, which is
consistent with the findings in Figure 1. However, the pattern of
increases in brain activation differed between the 2 groups.
Under the low WM load (1> 0-back), the noncarriers showed
increased activation in some regions of right frontal lobe,
whereas the Met allele carriers showed increased activation
in some regions of left frontal and right lateral parietal lobes.
Under the high WM load (2> 1-back), both groups showed
further activation in regions of the lateral and medial frontal and
the medial parietal regions bilaterally. Activation difference
TABLE 1. The Demographic Information, Cognitive Function, and Accuracy Rates of n-back WM in the Participants
Met (N¼ 9) Metþ (N¼ 11)
Met versus Metþ
t P
Gender (male, female) 5,4 5,6  
Mean age (SD), years 49.111 (4.01) 46.364 (6.80) 1.07 0.30
Handedness Right 9; Left 0 Right 11; Left 0  
Mean MMSE score (SD) 29.182 (1.08) 29.00 (1.00) 0.39 0.70
Mean AD8 score (SD) 0.22 (0.44) 0.36 (0.67) 0.54 0.596
0-back accuracy rate (SD) 0.95 (0.09) 0.89 (0.17) 1.04 0.32
1-back accuracy rate (SD) 0.94 (0.14) 0.89 (0.14) 0.94 0.36
2-back accuracy rate (SD) 0.87 (0.09) 0.83 (0.11) 1.07 0.31
AD8¼ eight-item informant interview to differentiate aging and dementia, BDNF¼ brain-derived neurotrophic factor, Met¼ non-BDNF Met-
allele carrier, Metþ¼BDNF Met-allele carrier, MMSE¼mini-mental status examination, WM¼working memory, SD¼ standard deviation.
P< 0.05 is statistically significant.
FIGURE 1. Activation maps of the BDNF Met allele carriers and
noncarriers in the n-back task in a surface-rendered projection
displayed on a standardized brain atlas (display threshold,
P<0.001; extent, 3 voxels). The averages of BOLD signals in
90 seconds of fixation in each single run were used as the contrast.
Activation in the bilateral frontal and parietal regions was
increased, consistent with the activation of WM circuitry in both
groups. In both groups, activation in left frontal region was more
prominent than that in the right frontal region, possibly repre-
senting right index finger movement during WM tasks.
BDNF¼brain-derived neurotrophic factor, BOLD¼blood
oxygenation level dependent, WM¼working memory.
FIGURE 2. Activation maps of the BDNF Met allele carriers and
noncarriers under 1>0-back and 2>1-back conditions in a sur-
face-rendered projection displayed on a standardized brain atlas
(display threshold, P<0.001; extent, 3 voxels). In both groups,
brain activation increased in response to each increase in the WM
load. Under the high WM load (2>1-back), both groups showed
further activation in the lateral and medial frontal regions and
medial parietal regions bilaterally. BDNF¼brain-derived neuro-
trophic factor, WM¼working memory.
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maps for 1> 0-back and 2> 1-back conditions between the 2
groups are shown in Figure 3. In both conditions, noncarriers
exhibit more brain activation in some brain regions than Met
allele carriers do. That is to say, the Met allele carriers exhibit
low brain activation in the right middle occipital, right superior
frontal, and right medial frontal gyri. The medial frontal gyrus is
the medial surface of the superior frontal gyrus (SFG), and the 2
gyri are referred to as the SFG collectively in the subsequent
section.
DISCUSSION
In the present study, we used a probability threshold value
with a high specificity (0.001) to demonstrate different brain
activation patterns during n-backWM tasks in BDNFMet allele
carriers and noncarriers. Two restricted brain areas with differ-
ent blood oxygenation level dependent (BOLD)-activation
between the Met allele carriers and noncarriers were revealed.
When the WM load increased, from 0- to 1-back and from 1- to
2-back, Met allele carriers showed lower brain activation in the
midline brain structure, specifically the SFG and middle occi-
pital gyrus (BA18). Brain activation in the dorsolateral pre-
frontal cortex, essential for coping with increasing brain activity
and WM loads,26 did not differ significantly between the 2
groups. Increased brain activation was observed in no brain
regions among the Met allele carriers.
The role of SFG in WM has been documented in several
studies27–29 and is responsible for continual update and WM
temporal order maintenance.30 Patients with left SFG lesions
exhibited poor n-back WM performance.31 Functional MRI
indicated that SFG, particularly spatial WM, is associated with
specialized WM functions.32–34 In addition, a recent fMRI
study demonstrated that SFG is involved in WM for shapes.35
Klingberg postulated a superior frontal-intraparietal network
implicated in visuospatial WM development.36 The role of the
occipital visual associate areas (BA18/19) in visuospatial WM
has been demonstrated in previous fMRI and PET studies.32,37–
39 The occipital visual associate areas are part of the proposed
dorsal visual pathway specialized in visuospatial information
processing; however, its role in numeral WM is unclear.
In our study, low BOLD activation in the SFG and middle
occipital gyrus in the BDNF Met allele carriers was observed
and can be explained by 2 possible mechanisms. The first is
defects in the WM network in BDNF Met allele carriers. In
previous animal and human studies, BDNF Met allele carriers
typically exhibited poor memory performance.7–11,40 If the
BDNFMet allele has a negative effect on memory performance,
it is rational to assume that low BOLD activation is due to
defective development of WM functioning during brain matu-
ration.41 The SFG and middle occipital gyrus are considered to
be involved specifically in visuospatial WM; therefore, com-
pensatory suppression of these regions might occur for main-
taining performance in the visual number-based n-back task in
Met allele carriers with WM network defects. However, as
mentioned in the Introduction, studies have yielded contra-
dictory results.14,15 Efficient use of the intact WM network
in BDNF Met allele carriers is another possible explanation for
low BOLD activation.
This study has a few limitations. First, serum BDNF
levels were not analyzed and correlated to the fMRI results.
Although the relationship is controversial, several studies have
reported low serum BDNF levels amongMet allele carriers.42–
44 Second, the genetic dose effect of the Met allele on brain
activation during WM tasks was not analyzed because of the
relatively low number of homozygous Met allele carriers. The
genetic dose effect of the BDNF Met allele has been reported
by studies examining the hippocampal N-acetyl aspartate level
by using magnetic resonance spectroscopy and hippocampal
activity during episodic memory tasks.6–15 Whether the dose
effect of the BDNF Met allele exists during WM tasks is
unknown. Third, this fMRI study recruited only 11 Met allele
carriers and 9 noncarriers among 110 participants, generating a
bias and a generalization problem. Additional investigations
with a large sample and long-term follow-up for exploring the
real cause of low SFG activation in n-back WM tasks
are warranted.
In summary, activation patterns seem to differ between
BDNF Met allele carriers and noncarriers during WM tasks. A
major difference was observed in the SFG and middle occipital
gyrus. Further investigation of the mechanism underlying the
influence of the BDNF Met allele on the SFG and middle
occipital gyrus is warranted.
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